Sutro Biopharma, Inc. (STRO)
24.45
-0.09
(-0.37%)
USD |
NASDAQ |
Mar 12, 16:00
23.01
-1.44
(-5.89%)
Pre-Market: 08:31
Sutro Biopharma Total Assets (Quarterly) : 209.66M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| GT Biopharma, Inc. | 8.106M |
| Rhythm Pharmaceuticals, Inc. | 481.19M |
| Crinetics Pharmaceuticals, Inc. | 1.135B |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 296.93M |
| Shareholders Equity (Quarterly) | -87.27M |
| Debt to Equity Ratio | -2.607 |
| Current Ratio | 2.533 |
| Net Debt Paydown Yield | -10.04% |